S100A10 and colorectal carcinoma: Shang et al. find that S100A10 overexpressions in CRC can enhance oxaliplatin (L-OHP) sensitivity [37, 38], which is consistent with our results that S100A10 overexpressions significantly associate with longer OS of CRC patients.